![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Pharmacokinetics, Safety and Tolerability of Tenofovir exalidex (CMX157), a Novel Prodrug of Tenofovir, Administered as Ascending Multiple Doses to Healthy Volunteers and HBV-Infected Subjects
|
|
|
Reported by Jules Levin
EASL 2017 April 19-23 Amsterdam Netherlands
Tawesak Tanwandee, MD, Somruedee Chatsiricharoenkul, MD,
Pisit Tangkijvanich, MD, Satawat Thongsawat, MD, Wattana Sukeepaisarnjaroen, MD, Anchalee Avihigsanon, MD, Piyawat Komolmit, MD, and Teerha Piratvisuth, MD
![0505171](../images/050517/050517-4/0505171.gif)
![0505172](../images/050517/050517-4/0505172.gif)
![0505173](../images/050517/050517-4/0505173.gif)
![0505174](../images/050517/050517-4/0505174.gif)
![0505175](../images/050517/050517-4/0505175.gif)
![0505176](../images/050517/050517-4/0505176.gif)
![0505177](../images/050517/050517-4/0505177.gif)
![0505178](../images/050517/050517-4/0505178.gif)
![0505179](../images/050517/050517-4/0505179.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|